Breaking News Instant updates and real-time market news.

M

Macy's

$21.07

0.44 (2.13%)

, WMT

Wal-Mart

$96.62

0.21 (0.22%)

13:29
11/24/17
11/24
13:29
11/24/17
13:29

On The Fly: Top stock stories for Friday

Stocks on Wall Street finished the Black Friday trading session higher, aided by a rise in a number of retailers' stocks. Macy's (M) was among the day's advancers, gaining over 2.1%, while Wal-Mart (WMT) finished fractionally higher and Target (TGT) was a noteworthy laggard, sliding 2.8%. ECONOMIC EVENTS: In the U.S., Markit's manufacturing PMI fell 0.8 points to 53.8 in the preliminary November reading. The preliminary November services PMI dipped 0.6 points to 54.7. COMPANY NEWS: Shares of BASF (BASFY) trading in New York advanced 3.65% after the company confirmed that it is in discussions regarding a potential merger of BASF Group's oil and gas activities with Letter One's oil and gas activities bundled in the DEA Group... Teva (TEVA) shares rose 1.63% following a report in the Israeli local business daily Calcalist that the company intends to cut as much as 25% of its Israeli workforce as well as more than 10% of its U.S.-based workers and some in Europe... DISH Network (DISH) announced that it has reached a multi-year carriage agreement with CBS (CBS) for its owned and operated local stations, as well as CBS Sports Network and other channels. Terms of the agreement were not disclosed. MAJOR MOVERS: Among the noteworthy gainers was Advanced Semiconductors (ASX), which gained more than 12% after the company and Siliconware Precision (SPIL) said that their merger has now received all necessary antitrust clearances. Among the notable losers was Qudian (QD), which fell over 24% in New York after it was informed by Ant Financial that for all transactions effective from November 30 on Alibaba's (BABA) Alipay consumer interface, an effective annualized rate of 24%, covering all interest, fees and charges, will be the maximum rate allowed for credit services for all third-party service providers. Also lower was Vipshop (VIPS), which slipped 3.55% after IBCI analyst Vicky Wu downgraded the stock to Hold from Buy. INDEXES: The Dow rose 31.81, or 0.14%, to 23,557.99, the Nasdaq gained 21.80, or 0.32%, to 6,889.16, and the S&P 500 advanced 5.34, or 0.21%, to 2,602.42.

M

Macy's

$21.07

0.44 (2.13%)

WMT

Wal-Mart

$96.62

0.21 (0.22%)

TGT

Target

$55.88

-1.61 (-2.80%)

BASFY

BASF

$27.39

-0.13 (-0.47%)

TEVA

Teva

$13.70

0.22 (1.63%)

CBS

CBS

$56.54

0.3 (0.53%)

DISH

Dish

$50.43

0.39 (0.78%)

ASX

Advanced Semiconductor

$7.07

0.76 (12.04%)

SPIL

Siliconware Precision

$7.94

-0.05 (-0.63%)

QD

Qudian

$12.22

-3.93 (-24.33%)

BABA

Alibaba

$191.19

1.35 (0.71%)

VIPS

Vipshop

$8.14

-0.3 (-3.55%)

  • 24

    Nov

  • 20

    Feb

  • 18

    Mar

M Macy's
$21.07

0.44 (2.13%)

10/30/17
SBSH
10/30/17
DOWNGRADE
Target $16
SBSH
Sell
Macy's downgraded to Sell from Neutral at Citi
Citi analyst Paul Lejuez downgraded Macy's (M) to Sell and cut his price target for the shares to $16 from $21. The retailer's sales and margins have been pressured for several years, and J.C. Penney's (JCP) weak Q3 preannouncement on Friday serves as reminder of just how challenging the department store space is, Lejuez tells investors in a research note. He believes risks are mounting at Macy's ahead of what is likely to be another promotional holiday season. Macy's has not found the right tools to offset negative store traffic and margin pressures, the analyst contends. Lejuez this morning also downgraded Penny to Sell.
10/17/17
MSCO
10/17/17
NO CHANGE
MSCO
Survey points to Amazon gaining traction in apparel, says Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger said the results of the firm's latest apparel survey lend support to her belief that Amazon (AMZN) is quickly gaining traction in the space at the expense of department stores and select specialty retailers. Nordstrom (JWN) and Macy's (M) showed above average risk with 84% and 81% Amazon shopper overlap, noted Greenberger. She also noted that Urban Outfitters' (URBN) Anthropologie, Abercrombie & Fitch (ANF) and Gap's (GPS) Banana Republic were among the brands that registered declines in respondents' net purchase intentions over the next 12 months.
10/30/17
10/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. General Motors (GM) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying his price target of $32 offers 28% potential downside. The analyst continues to believe the North America auto cycle has peaked and he remains cautious on the sector. 2. Merck (MRK) downgraded to Hold from Buy at SunTrust and to Equal Weight from Overweight at Morgan Stanley, as well as Barclays. 3. J.C. Penney (JCP) downgraded to Sell from Neutral at Citi, to Neutral from Buy at Northcoast, and to Neutral from Positive at Susquehanna. 4. Macy's (M) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez saying the retailer's sales and margins have been pressured for several years, and J.C. Penney's weak third quarter preannouncement on Friday serves as reminder of just how challenging the department store space is. 5. Under Armour (UAA, UA) downgraded to Underperform from Neutral at BofA/Merrill with analyst Robert Ohmes saying he expects management to lower fourth quarter guidance on its Q3 conference call due to the highly promotional environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/09/17
JEFF
11/09/17
NO CHANGE
Target $20
JEFF
Hold
Jefferies sees some 'green shoots,' trims Macy's target to $20
Jefferies analyst Randal Konik says closely managed inventory lead to gross margin upside in Macy's Q3, which offset comp weakness. The analyst likes Macy's steps to drive traffic with initiatives across marketing, merchandising, and omni capabilities. He remains "guarded," however, around the secular headwinds in the mall-based department store space. In a post-earnings research note titled "Some Green Shoots Here, But We Remain Guarded L-Term," Konik lowered his price target for Macy's shares to $20 from $21 and keeps a Hold rating on the name.
WMT Wal-Mart
$96.62

0.21 (0.22%)

11/24/17
RHCO
11/24/17
NO CHANGE
RHCO
American Eagle, Old Navy look like holiday 'winners' based on SunTrust checks
SunTrust analyst Pamela Quintiliano said the mall she visited during her Thanksgiving checks was the most crowded she has seen on the holiday in years and that American Eagle (AEO) and Gap's (GPS) Old Navy appeared to be "winners" as they consistently had the longest register lines. Among big box retailers visited, Wal-Mart (WMT) and Kohl's (KSS) had more activity than others, added Quintiliano.
11/20/17
11/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler sayign valuation following "powerful" share appreciation now reflects the company's progress in growing earnings. 2. Five Below (FIVE) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation. 3. Live Nation (LYV) downgraded to In Line from Outperform at Evercore ISI with analyst David Joyce citing valuation. 4. Monster Beverage (MNST) downgraded to Negative from Neutral at Susquehanna with analyst Pablo Zuanic citing its high valuation, which he believes is misplaced due to assumptions about an offer from Coca-Cola (KO). 5. Deutsche Bank (DB) downgraded to Underperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/20/17
GSCO
11/20/17
DOWNGRADE
Target $100
GSCO
Wal-Mart downgraded to Neutral from on valuation at Goldman Sachs
As previously reported, Goldman downgraded Wal-Mart to Neutral from Buy and raised its price target to $100 from $91. Analyst Matthew Fassler said valuation following "powerful" share appreciation now reflects the company's progress in growing earnings.
11/20/17
GSCO
11/20/17
DOWNGRADE
GSCO
Neutral
Wal-Mart downgraded to Neutral from Buy at Goldman Sachs
TGT Target
$55.88

-1.61 (-2.80%)

11/03/17
WELS
11/03/17
INITIATION
Target $62
WELS
Market Perform
Target initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Edward Kelly started Target with a Market Perform rating and $62 price target. Target s one of the most exposed retailers to the digital threat, the analyst contends. He sees no catalyst for share outperformance at the moment.
10/09/17
MSCO
10/09/17
NO CHANGE
Target $84
MSCO
Equal Weight
Wal-Mart shares likely to rise if FY19 goal reiterated, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman noted that Wal-Mart (WMT) shares have underperformed ahead of the company's investor day, which is the first time this has been the case in 4 years. He attributes the underperformance to fears about the achievability of Wal-Mart's 5% EPS growth target in FY19 and Target's (TGT) recent wage announcement. Gutman, who sees only a 25% chance Wal-Mart backs away from this goal, thinks that if the 5% target is maintained, shares will "likely grind higher, perhaps by1%-2%." He keeps an Equal Weight rating and $84 price target on Wal-Mart shares.
11/08/17
11/08/17
DOWNGRADE
Target $15

Underweight
Sally Beauty cut to sell at Morgan Stanley as competition 'catches up'
As previously reported, Morgan Stanley analyst Simeon Gutman downgraded Sally Beauty to Underweight, the firm's equivalent to a sell rating, from Equal Weight. Its retail segment is facing tougher competition while its professional segment is decelerating, he stated. While the stock is down 15% since the company's Q3 report, that does not fully reflect the headwinds Sally Beauty faces amid competitive pressures from Wal-Mart (WMT) Target (TGT), Ulta (ULTA) and drugstores catch up, Gutman tells investors. He lowered his price target on Sally Beauty shares to $15 from $22.
11/15/17
BARD
11/15/17
NO CHANGE
Target $55
BARD
Neutral
Target modernization efforts weighing on profits, says Baird
Baird analyst Peter Benedict maintains a Neutral rating and $55 price target on Target shares following this morning's Q3 results. The retailer's Q4 outlook, with earnings down 20% year-over-year at the midpoint, "reinforced the cost of driving sales in a highly competitive backdrop," Benedict tells investors in a post-earnings research note. The analyst believes Target's modernization efforts are weighing on profits and he sees low visibility into a margin inflection.
BASFY BASF
$27.39

-0.13 (-0.47%)

01/19/17
JPMS
01/19/17
UPGRADE
JPMS
Overweight
BASF upgraded to Overweight from Underweight at JPMorgan
JPMorgan analyst Martin Evans yesterday double upgraded BASF to Overweight from Underweight saying he's turning more positive on European Chemicals.
11/22/17
BREN
11/22/17
UPGRADE
BREN
Buy
BASF upgraded to Buy from Hold at Berenberg
Berenberg analyst Sebastian Bray upgraded BASF to Buy.
02/13/17
EVER
02/13/17
INITIATION
EVER
Buy
BASF initiated with a Buy at Evercore ISI
Evercore ISI analyst Laurent Favre initiated BASF with a Buy rating and a EUR100 price target.
TEVA Teva
$13.70

0.22 (1.63%)

11/13/17
JPMS
11/13/17
DOWNGRADE
Target $11
JPMS
Underweight
Teva downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Chris Schott downgraded Teva Pharmaceuticals to Underweight saying he sees an "extended road to recovery and no clear fundamental inflection in sight" amid challenges in the company's U.S. generics business. The analyst sees more attractive opportunities elsewhere in the sector and keeps an $11 price target for Teva shares.
11/07/17
HSBC
11/07/17
DOWNGRADE
Target $6
HSBC
Reduce
Teva downgraded to Reduce from Hold at HSBC
HSBC analyst Steve McGarry downgraded Teva to Reduce and slashed his price target on shares to $6 from $26. The analyst reduced estimates to reflect margin compression and lack of earnings growth and said the balance sheet is "over-stretched." McGarry said equity holders now have a risky investment and any rights issue to de-leverage the balance sheet will dilute equity investors, and bondholders could insist on a debt-for-equity swap, which would also be painful.
11/24/17
WELS
11/24/17
NO CHANGE
WELS
Teva in 'survival mode at this point,' says Wells Fargo
Wells Fargo analyst David Maris says Teva is "in survival mode at this point" following reports that the company will soon announce a 20% workforce reduction. Given its "tough" debt position, Teva's nearly 5% share rally in Israel is not surprising, as it encourages some investors that the company will not face a restructuring, Maris tells investors in a research note. The analyst believes, however, that investors "should not confuse a lower cost base as an improvement, but rather steps for surviving longer." Maris thinks asset sales such as key pipeline products and brand products "will also be on the table." He keeps a Market Perform rating on Teva. The stock in premarket trading is up 4%, or 57c, to $14.05.
11/07/17
11/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Priceline (PCLN) downgraded to Neutral from Buy at Guggenheim. 2. Exxon Mobil (XOM) downgraded to Reduce from Hold at HSBC with analyst Gordon Gray saying he compares Exxon's valuation to Buy rated Shell's (RDS.A) saying it is a third higher, yet Shell generated $7B more underlying cash flow in the past 12 months, and he thinks Exxon's capex will rise by much more in 2018 in comparison. 3. Teva (TEVA) downgraded to Reduce from Hold at HSBC with analyst Steve McGarry saying the balance sheet is "over-stretched." 4. Cabot Oil & Gas (COG) downgraded to Hold from Buy at Drexel Hamilton with analyst Bob Christensen citing the temporary stay issued on the Atlantic Sunrise pipeline. 5. SMIC (SMI) downgraded to Underperform from Neutral at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CBS CBS
$56.54

0.3 (0.53%)

11/01/17
FBCO
11/01/17
NO CHANGE
Target $38
FBCO
Outperform
Viacom price target lowered to $38 from $45 at Credit Suisse
Credit Suisse analyst Omar Sheikh lowered his price target for Viacom (VIAB) to $38 from $45 saying the rationale for re-combining CBS (CBS) and Viacom is becoming "increasingly hard" for controlling shareholder National Amusements to ignore. The analyst notes that a merger would transform Viacom's negotiating leverage with distributors long-term, generate greater than $400M of cost synergies, solve Viacom's leverage issue, and give it time and capital to invest in its core networks. Sheikh reiterates an Outperform rating on Viacom's shares.
09/15/17
JPMS
09/15/17
NO CHANGE
Target $75
JPMS
Overweight
CBS recent share weakness overdone, says JPMorgan
JPMorgan analyst Alexia Quadrani views the recent pullback in shares of CBS (CBS) as overdone. The stock has underperformed over the prior month, down 12% versus the S&P 500 Index up 1%, Quadrani tells investors in a research note titled "Weather Channel's Gain is NFL's Pain; CBS Weakness Overdone." The analyst attributes yesterday's selloff to NFL ratings for week one, which declined 12% year-over-year. It is unreasonable to draw conclusions from just one weekend of games, especially last weekend given the storms, the analyst argues. Further, Quadrani says CBS CEO Les Moonves' comment yesterday that Amazon (AMZN) would be interested in bidding for NFL rights when they come due early next decade is "hardly news." She keeps an Overweight rating on CBS with a $75 price target.
09/13/17
NEED
09/13/17
NO CHANGE
NEED
CBS Internet video channels could be worth $7.2B, says Needham
Needham analyst Laura Martin estimates that CBS' (CBS) Internet video services could generate $1.2B of revenue in 2020. She notes that Netflix's (NFLX) market cap is six times its revenue. If CBS' Internet video services are valued using that multiple, they would be worth $7.2B, or 30% of CBS' current market cap, according to the analyst. She keeps an $80 price target and a Buy rating on the shares.
09/19/17
09/19/17
NO CHANGE

Cowen lowers price targets on media companies
Cowen analyst Doug Crentz cut his price targets for several media companies, as he believes that the margin pressure on TV networks will continue. The analyst believes that consensus estimates for TV broadcasters are too high, as he expects that the decline in the sector's EBITDA margin will more than double this year, driven by lower ad and affiliate revenue. He believes that two "deep-pocketed, low margin competitors -Netflix (NFLX) and Amazon (AMZN) - are the root of the problem. He cut his price target on Viacom (VIAB) to $31 from $41, on Discovery (DISCA) to $19 from $25, on Fox (FOXA) to $29 from $32, on CBS (CBS) to $69 from $70 and on Disney (DIS) to $94 from $95.
DISH Dish
$50.43

0.39 (0.78%)

10/17/17
HSBC
10/17/17
NO CHANGE
Target $52
HSBC
Hold
Dish price target lowered to $52 from $63 at HSBC
HSBC analyst Sunil Rajgopal said Dish (DISH) is in a difficult position given consumers' increasing preference for OTT video and migration to low-tiered packages, combined with limited progress on spectrum monetization. The analyst believes the potential tie-up of Sprint (S) and T-Mobile (TMUS) reduces the prospects of Dish's entry into wireless further and lowers its bargaining power in any future spectrum monetization talks. Rajgopal has turned more bearish on Dish's subscriber trends and expects 391K traditional subs losses in Q3 and 759K subs losses in 2018, and cut estimates for 2017-19. As a result, the analyst moves his price target on shares to $52 from $63 and maintains a Hold rating.
10/05/17
DBAB
10/05/17
NO CHANGE
Target $99
DBAB
Buy
Deutsche hears 'clearer narrative' from DISH, keeps $99 price target
After Dish CEO Charlie Ergen participated in a fireside chat presentation at his firm's Leveraged Finance Conference on Tuesday, Deutsche Bank analyst Bryan Kraft keeps a Buy rating on the shares with a $99 price target. Following "more muddled messaging" on the company's Q2 earnings call, which drove the shares lower over the past two months, a "clearer narrative" is emerging at Dish, Kraft tells investors in a research note. The analyst sees "strong potential" for long term value creation through the monetization or utilization of Dish's core asset, its wireless spectrum. The option Dish seems most active in pursuing is the creation of a Neutral Host model that provides connectivity and related services to commercial and governmental customers primarily for Internet of Things applications, Kraft writes. He notes that Ergen highlighted 2020 as the year when the company would be in a position to begin implementing the NH strategy.
11/06/17
PIVT
11/06/17
UPGRADE
Target $65
PIVT
Buy
Dish upgraded to Buy from Hold at Pivotal Research
Pivotal Research analyst Jeffrey Wlodarczak upgraded Dish Network (DISH) to Buy saying recent underperformance has brought an attractive risk/reward profile for the shares. The analyst sees a "reasonable chance" of T-Mobile (TMUS) making a play for Dish or Dish spectrum after the company failed to reach a merger agreement with Sprint (S). Such a move would "immediately vault the most disruptive U.S. wireless player into the leading U.S. spectrum position," Wlodarczak tells investors in a research note. He believes that a T-Mobile overture could force Verizon (VZ) to counterbid for Dish spectrum, or possibly the entire company, noting that the spectrum is "ideally suited" for Verizon. The analyst trimmed his price target for Dish shares to $65 from $68.
10/17/17
MSCO
10/17/17
NO CHANGE
Target $75
MSCO
Overweight
Dish pullback a buying opportunity, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne notes that Dish Network shares are down about 25% since the company's Q2 earnings report. At these levels, he equates the share price to the equivalent of either getting a 45% discount to his estimated value for its mid-band spectrum or getting a steep discount on the multiple for its pay-TV business, he tells investors. However, strategic options exist for both assets, said Swinburne, who views the slide in the stock as an opportunity. He keeps an Overweight rating and $75 price target on Dish Network shares.
ASX Advanced Semiconductor
$7.07

0.76 (12.04%)

11/25/16
GSCO
11/25/16
DOWNGRADE
GSCO
Neutral
Advanced Semiconductor downgraded to Neutral from Buy at Goldman
12/16/16
12/16/16
NO CHANGE

Advanced Semiconductor files to sell stock and rights to subscribe for stock
SPIL Siliconware Precision
$7.94

-0.05 (-0.63%)

QD Qudian
$12.22

-3.93 (-24.33%)

11/24/17
MACQ
11/24/17
NO CHANGE
Target $24
MACQ
Outperform
Qudian price target lowered to $24 from $36 at Macquarie
Macquarie analyst Dexter Hsu lowered his price target for Qudian shares to $24 after Ant Financial asked the company and its peers to cap the annual percentage rate at 24%, below the 34% charged by Qudian, from the end of this month if they would like to stay in the ecosystem. While Alipay still accounts for two-thirds of Qudian's loans facilitated, the impact could be smaller than expected since the company has been directing users to its own app, where the annual percentage rate will stay at 36%, Hsu tells investors in a research note. Nonetheless, he cut his 2017, 2018, 2019 and 2020 earnings estimates by 8%, 23%, 32% and 39%, respectively. The analyst keeps an Outperform rating on Qudian shares.
11/21/17
STFL
11/21/17
NO CHANGE
STFL
Qudian not subject to proposed regulations, buy shares, says Stifel
11/21/17
STFL
11/21/17
NO CHANGE
Target $35
STFL
Buy
Stifel says regulation headlines misinterpreted, buy Qudian shares
Stifel analyst John Davis recommends buying shares of Qudian on today's weakness after Bloomberg reported that Chinese authorities are suspending online small-loan company approvals. The stock in morning trading is down 13% to $17.43. After speaking to management, Davis believes the regulation referred to in the Bloomberg story would only apply to new companies attempting to enter the small loan marketplace. Qudian, which is already licensed in China, would not be subject to the proposed regulation, the analyst tells investors in a research note. He believes that if anything, the regulation would create a competitive advantage for Qudian, as it creates a significant barrier to entry. Davis has a Buy rating on the shares with a $35 price target.
11/24/17
SBSH
11/24/17
NO CHANGE
Target $38.79
SBSH
Buy
Qudian user growth to see limited impact from new rules, says Citi
Citi analyst Daphne Poon believes Alipay's new annualized rate cap of 24% will have a limited impact on Qudian's user growth. The analyst sees pressure on new user growth being "relatively limited" given Qudian's "strong brand recognition, large existing user base, and strong consumption scenario." Poon believes the company enjoys stronger borrower engagement ability than peers. The analyst does, however, see more potential for an earnings hit from the lower APR on loans facilitated via Alipay, especially for first time borrowers. If 20% of Qudian's loan volume is originated from Alipay and subject to the 24% APR cap, it will lower Qudian's 2018 earnings net profit after tax by 10%, the analyst tells investors in a research note. Poon keeps a Buy rating on Qudian with a $38.79 price target.
BABA Alibaba
$191.19

1.35 (0.71%)

11/06/17
OPCO
11/06/17
NO CHANGE
Target $220
OPCO
Outperform
Alibaba price target raised to $220 from $200 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Alibaba to $220 from $200, while reiterating an Outperform rating on the shares, after another "strong quarter." The analyst believes Alibaba is uniquely positioned to benefit from the rise of Chinese middle-class consumption.
11/07/17
OPCO
11/07/17
NO CHANGE
Target $99
OPCO
Outperform
Altaba price target raised to $99 from $75 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Altaba (AABA) to $99 from $75 following a more bullish outlook for the shares and due to Alibaba's (BABA) price target increase to $220 from $200. The analyst reiterates an Outperform rating on Altaba's shares.
11/13/17
WELS
11/13/17
NO CHANGE
WELS
Outperform
Alibaba Single's Day GMV surpasses Black Friday/Cyber Monday, says Wells Fargo
Wells Fargo analyst Ken Sena notes that Alibaba announced Gross Merchandise Value of 168B/$25B during this year's "Singles Day" shopping festival, or 39% year over year, an acceleration when compared to 32% year over year last year and 19% above his estimate of $21B. While the company no longer discloses quarterly GMV, the $25B number accounts for roughly 11% of the analyst's current estimate of Alibaba's Q3 2018 GMV of $222B and is 27% above the $19.7B sales expected in the U.S. this year between Thanksgiving and Cyber Monday. Sena reiterates an Outperform rating on the shares.
11/13/17
BARD
11/13/17
NO CHANGE
Target $210
BARD
Outperform
Singles Day topped expectations for Alibaba, says Baird
Baird analyst Colin Sebastian noted Alibaba's Singles Day performance topped expectations, which he believes bodes well for its Q3 results and spotlights its data advantage to drive omni-channel growth. Sebastian reiterated his Outperform rating and $210 price target on Alibaba shares.
VIPS Vipshop
$8.14

-0.3 (-3.55%)

10/30/17
UBSW
10/30/17
INITIATION
Target $9
UBSW
Neutral
Vipshop initiated with a Neutral at UBS
UBS analyst Jerry Liu initiated Vipshop with a Neutral rating citing investors concerns about its limited growth and profitability. He also noted expenses have increased in each of the past 12 quarters. However, with the shares trading at all-time low valuations, he believes the headwinds are already priced in. Liu has a $9.00 price target on Vipshop shares.
10/30/17
10/30/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sotheby's (BID) initiated with a Buy at Aegis. 2. Alnylam (ALNY) initiated with a Buy at FBR Capital. 3. Adamas Pharmaceuticals (ADMS) initiated with an Outperform at Evercore ISI. 4. Vipshop (VIPS) initiated with a Neutral at UBS. 5. Rhythm Pharmaceuticals (RYTM) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/22/17
JPMS
11/22/17
NO CHANGE
Target $10
JPMS
Overweight
Vipshop price target lowered to $10 from $13 at JPMorgan
JPMorgan analyst Alex Yao lowered his price target for Vipshop to $10 saying "weak" user growth in Q3 is the result of light marketing spend. He expects the company's revenue growth to decelerate to 18% in 2018 due to elevated competition in the apparel vertical. User growth will likely remain soft, but average revenue per user should continue to drive revenue growth, Yao tells investors in a research note. He maintains an Overweight rating on Vipshop citing valuation.
11/24/17
11/24/17
DOWNGRADE

Vipshop downgraded to Hold from Buy at ICBCI
ICBCI analyst Vicky Wu downgraded Vipshop to Hold and cut her price target for the shares to $9.50 from $9.80.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

13:17
12/18/17
12/18
13:17
12/18/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
12/18/17
12/18
13:16
12/18/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$31.46

0.16 (0.51%)

13:15
12/18/17
12/18
13:15
12/18/17
13:15
Options
Goodyear Tire put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 16

    Jan

CSX

CSX

$52.93

-4.38 (-7.64%)

, CP

Canadian Pacific

$179.01

0.33 (0.18%)

13:12
12/18/17
12/18
13:12
12/18/17
13:12
Hot Stocks
CSX CEO death raises questions about strategy, M&A potential »

Shares of CSX (CSX) are…

CSX

CSX

$52.93

-4.38 (-7.64%)

CP

Canadian Pacific

$179.01

0.33 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AMED

Amedisys

$55.31

0.93 (1.71%)

13:11
12/18/17
12/18
13:11
12/18/17
13:11
Technical Analysis
Technical View: Amedisys off earlier lows, levels to watch »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

BCS

Barclays

$10.89

0.195 (1.82%)

, SDRL

Seadrill

$0.26

-0.0097 (-3.65%)

13:02
12/18/17
12/18
13:02
12/18/17
13:02
Periodicals
Barclays submits alternative proposal to restructure Seadrill, Reuters reports »

Barclays (BCS) has…

BCS

Barclays

$10.89

0.195 (1.82%)

SDRL

Seadrill

$0.26

-0.0097 (-3.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMED

Amedisys

$55.31

0.93 (1.71%)

, LHCG

LHC Group

$61.86

1.38 (2.28%)

13:01
12/18/17
12/18
13:01
12/18/17
13:01
Hot Stocks
Home health-care providers fall on report of potential Humana-Kindred deal »

Shares of home health…

AMED

Amedisys

$55.31

0.93 (1.71%)

LHCG

LHC Group

$61.86

1.38 (2.28%)

AFAM

Almost Family

$57.00

0.6 (1.06%)

HUM

Humana

$247.94

-5.7 (-2.25%)

KND

Kindred Healthcare

$9.10

0.5 (5.81%)

SEM

Select Medical

$16.50

-0.15 (-0.90%)

AET

Aetna

$178.86

-0.84 (-0.47%)

UNH

UnitedHealth

$222.58

0.7597 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

NQ

NQ Mobile

$3.97

0.23 (6.15%)

13:00
12/18/17
12/18
13:00
12/18/17
13:00
Options
Second day of notable call activity in NQ Mobile »

Second day of notable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:00
12/18/17
12/18
13:00
12/18/17
13:00
General news
NASDAQ comp poked above 7k for the first time »

NASDAQ comp poked above…

12:55
12/18/17
12/18
12:55
12/18/17
12:55
General news
FX Action: USD-JPY »

FX Action: USD-JPY found…

CHCT

Community Healthcare

$28.14

-0.08 (-0.28%)

12:49
12/18/17
12/18
12:49
12/18/17
12:49
Initiation
Community Healthcare initiated  »

Community Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PENN

Penn National

$29.69

0.44 (1.50%)

, PNK

Pinnacle Entertainment

$30.95

-0.15 (-0.48%)

12:47
12/18/17
12/18
12:47
12/18/17
12:47
Recommendations
Penn National, Pinnacle Entertainment analyst commentary  »

Penn National price…

PENN

Penn National

$29.69

0.44 (1.50%)

PNK

Pinnacle Entertainment

$30.95

-0.15 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

RIOT

Riot Blockchain

$28.50

3.52 (14.09%)

12:45
12/18/17
12/18
12:45
12/18/17
12:45
Options
Riot Blockchain Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$66.46

0.51 (0.77%)

, DRI

Darden

$90.46

2.05 (2.32%)

12:44
12/18/17
12/18
12:44
12/18/17
12:44
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CCL

Carnival

$66.46

0.51 (0.77%)

DRI

Darden

$90.46

2.05 (2.32%)

FDS

FactSet

$202.21

-2.66 (-1.30%)

NAV

Navistar

$41.94

1.37 (3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Dec

  • 19

    Dec

  • 19

    Dec

  • 08

    Jan

  • 08

    Jan

HEI

Heico

$96.53

0.4 (0.42%)

12:44
12/18/17
12/18
12:44
12/18/17
12:44
Earnings
Notable companies reporting after market close »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

DCIX

Diana Containerships

$5.44

0.57 (11.70%)

12:42
12/18/17
12/18
12:42
12/18/17
12:42
Hot Stocks
Breaking Hot Stocks news story on Diana Containerships »

Trend Discovery reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$180.18

1.79 (1.00%)

12:34
12/18/17
12/18
12:34
12/18/17
12:34
Periodicals
WhatsApp could be fined in France over Facebook data sharing, Reuters reports »

French data protection…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

  • 07

    Feb

RF

Regions Financial

$17.34

0.22 (1.29%)

12:25
12/18/17
12/18
12:25
12/18/17
12:25
Options
Regions Financial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
12/18/17
12/18
12:25
12/18/17
12:25
General news
Treasury Option Action: a round of put buying »

Treasury Option Action: a…

CSX

CSX

$52.93

-4.38 (-7.64%)

, HSY

Hershey

$115.13

0.985 (0.86%)

12:18
12/18/17
12/18
12:18
12/18/17
12:18
General news
On The Fly: Top stock stories at midday »

Stocks opened sharply…

CSX

CSX

$52.93

-4.38 (-7.64%)

HSY

Hershey

$115.13

0.985 (0.86%)

CPB

Campbell Soup

$49.97

0.38 (0.77%)

LNCE

Snyder's-Lance

$46.79

2.37 (5.34%)

BETR

Amplify Snack Brands

$11.95

4.945 (70.64%)

KND

Kindred Healthcare

$9.13

0.525 (6.10%)

HUM

Humana

$248.20

-5.44 (-2.14%)

PNK

Pinnacle Entertainment

$30.95

-0.15 (-0.48%)

PENN

Penn National

$29.69

0.44 (1.50%)

DAL

Delta Air Lines

$56.27

0.165 (0.29%)

TWTR

Twitter

$24.07

1.8358 (8.26%)

AKAM

Akamai

$57.76

1 (1.76%)

SCG

Scana

$42.92

-1.5 (-3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 08

    Jan

  • 11

    Jan

  • 07

    Feb

$NSD

NASDAQ Market Internals

12:17
12/18/17
12/18
12:17
12/18/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/18/17
12/18
12:16
12/18/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$173.97

1.75 (1.02%)

, AMZN

Amazon.com

$1,179.14

4.88 (0.42%)

12:15
12/18/17
12/18
12:15
12/18/17
12:15
Periodicals
Apple AirPods appear to be sold out through the holidays, CNBC reports »

Apple's (AAPL)…

AAPL

Apple

$173.97

1.75 (1.02%)

AMZN

Amazon.com

$1,179.14

4.88 (0.42%)

BBY

Best Buy

$66.39

1.07 (1.64%)

TGT

Target

$63.77

1.16 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

SGMO

Sangamo

$16.35

-0.05 (-0.30%)

12:15
12/18/17
12/18
12:15
12/18/17
12:15
Options
Sangamo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXT

Sensient

$74.91

-0.79 (-1.04%)

12:07
12/18/17
12/18
12:07
12/18/17
12:07
Recommendations
Sensient analyst commentary  »

Sensient lower following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.